Mersana Therapeutics buy JPMorgan Chase & Co.
Start price
16.03.23
/
50%
€4.32
Target price
16.03.24
€9.45
Performance (%)
3.36%
End price
17.03.24
€4.47
Summary
This prediction ended on 17.03.24 with a price of €4.47. With a performance of 3.36%, the BUY prediction by JPMorgan_Chase___Co_ for Mersana Therapeutics closed with a slight gain. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Mersana Therapeutics | -7.216% | -7.216% | -48.110% |
iShares Core DAX® | 1.395% | -0.272% | 17.642% |
iShares Nasdaq 100 | 2.287% | 6.912% | 37.651% |
iShares Nikkei 225® | 1.617% | 3.038% | 12.910% |
iShares S&P 500 | 0.659% | 3.687% | 29.434% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $10.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten